Skip to content

AI-powered review readiness assessment

Will your ePrint survive MLR review?

Know within 48 hours whether your publication is likely to encounter Medical, Legal and Regulatory challenges — before committing valuable reviewer time.

SecureChek AI is a readiness assessment. It does not perform, approve or replace MLR review.

Review Readiness Report

Illustrative

72

Review Readiness Score

Risk rating: Medium

  • Claims extracted34
  • Aligned with approved labeling29
  • Red Flags raised3
  • Assessment returned48 hrs

Watch

Is this thing going to fly, or not?

A two-minute explanation of how a Review Readiness Assessment answers that question before your reviewers open the file.

Product film — coming soon

Placeholder frame. The final film will be embedded here.

The problem

Why are medical reprints delayed?

The science is ready long before the approval is. Every week in the queue is a week the evidence is not in front of a physician.

  1. Publication accepted

    Peer-reviewed evidence is finally in print.

  2. Medical Affairs excited

    The data answers questions physicians are asking.

  3. MLR queue

    The article joins a queue behind everything else.

  4. Weeks pass

    Reviewers re-read the label, the SmPC, the references.

  5. Nothing reaches HCPs

    The evidence sits, unusable, in a shared drive.

  6. Opportunity lost

    The moment of clinical relevance has moved on.

By the numbers

89%
Physicians value medical reprints

Figure being validated

Weeks
Typical MLR delay

Varies by organisation

48 hours
SecureChek AI assessment

From submission

Why traditional MLR takes so long

Every claim is compared, by hand, against six sources

Reviewers read a journal article line by line and cross-check each statement against labeling, references and promotional guidance. It is careful, necessary work — and it is slow.

  • Journal article
  • FDA Label
  • SmPC
  • Approved claims
  • References
  • Promotional guidance

SecureChek AI

Performs this comparison automatically, then hands reviewers a ranked list of what to look at.

Reviewers keep the judgment. The cross-referencing is done before they start.

How it works

How quickly can I know whether an ePrint is likely to pass review?

Seven steps from submission to deployment. The first five happen inside 48 hours.

  1. 148 hrs

    Submit article

    Upload the journal article or ePrint through a simple form.

  2. 248 hrs

    AI creates claims library

    Every statement of efficacy, safety and use is extracted.

  3. 348 hrs

    Compare against approved labeling

    Each claim is matched to label, SmPC and references.

  4. 448 hrs

    Generate Review Readiness Score

    An overall score and risk rating within 48 hours.

  5. 548 hrs

    Highlight Red Flags

    Evidence-linked issues, ranked by severity.

  6. 6

    Human MLR review

    Your reviewers apply professional judgment where it matters.

  7. 7

    Commercial deployment

    Approved evidence reaches HCPs sooner.

The product

What do I receive? A Review Readiness Report.

One document, delivered within 48 hours of submission, that tells you whether this is likely to fly.

Review Readiness Report

Illustrative

72

Review Readiness Score

Risk rating: Medium

  • Claims extracted34
  • Aligned with approved labeling29
  • Red Flags raised3
  • Assessment returned48 hrs

Overall score

A single Review Readiness Score for the article.

Risk rating

Low, medium or high, with the reasoning behind it.

Red Flags

Each potential MLR challenge, ranked by severity.

Supporting evidence

The exact passage in the article that triggered the flag.

Referenced label section

The clause of the approved labeling it conflicts with.

Suggested reviewer focus

Where human attention will pay off most.

Red Flags

Every flag is explained, evidenced and traceable

Illustrative examples. Red Flags are indicative findings for human review — they are not approval decisions.

Off-label indication

High

Article discusses use in COPD. The product is only licensed for asthma maintenance.

Referenced label section
Indications and Usage — asthma maintenance treatment
Status
Requires MLR review

Unsupported superiority claim

Medium

The article implies superiority. The evidence cited supports equivalence rather than superiority.

Referenced label section
Clinical Studies — non-inferiority endpoint
Status
Requires MLR review

Product tour

See SecureChek AI in action

Four steps, one outcome: a confident decision about whether to spend reviewer time.

Submit

A short form: the article, the product, the approved labeling set.

Submit — interface preview

Inside the product

What the platform looks like

Preview placeholders. Final interface imagery will be published as each screen is released.

Submission form

Review report

Review Readiness Score

Red Flag report

Future dashboard

Business value

Where the time and effort is recovered

Qualitative outcomes reported by teams working through reprint approval. Quantified figures will be published once independently validated.

Reduce reviewer effort

Reviewers start with the issues, not the cross-referencing.

Identify issues earlier

Problems surface before internal review time is committed.

Accelerate evidence distribution

Approved reprints reach HCPs closer to publication.

Reduce agency rework

Fewer late-stage changes after production work is complete.

Improve consistency

The same label-alignment standard applied every time.

Support global launch teams

A repeatable readiness check across markets.

Scope and boundaries

Built for the teams who carry the review burden

Designed for

  • Medical Affairs
  • Commercial Excellence
  • Medical Information
  • Regulatory Affairs
  • Medical Communications
  • Medical Review
  • Global Brand Teams

What SecureChek AI does not do

  • Does not replace MLR
  • Does not approve promotional material
  • Does not replace medical reviewers
  • Does not publish content automatically

Instead, it helps reviewers focus attention where it matters.

Applications

One readiness engine, several applications

ePrint validation is the first application. Others follow as each solution area is released.

Get started

Book an exploratory call

We will show how a Review Readiness Assessment answers one question in 48 hours: is this ePrint likely to fly, or not?

  • 30-minute exploratory conversation, no demo script
  • Walk through a sample Review Readiness Report
  • No obligation, no procurement steps required

We use your details only to respond to this enquiry.